Your browser doesn't support javascript.
loading
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.
Beauverd, Yan; Roosnek, Eddy; Tirefort, Yordanka; Nagy-Hulliger, Monika; Bernimoulin, Michael; Tsopra, Olga; Ansari, Marc; Dantin, Carole; Casini, Alessandro; Grandjean, Anne-Pascale; Chigrinova, Ekaterina; Masouridi-Levrat, Stavroula; Chalandon, Yves.
Affiliation
  • Beauverd Y; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Roosnek E; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Tirefort Y; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Nagy-Hulliger M; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Bernimoulin M; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Tsopra O; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Ansari M; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Dantin C; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Casini A; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Grandjean AP; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Chigrinova E; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Masouridi-Levrat S; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland.
  • Chalandon Y; Stem Cell Transplant Team, Division of Hematology, Geneva's University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland. Electronic address: yves.chalandon@hcuge.ch.
Biol Blood Marrow Transplant ; 20(9): 1322-8, 2014 Sep.
Article in En | MEDLINE | ID: mdl-24769318

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Homologous / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2014 Document type: Article Affiliation country: Switzerland Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Homologous / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2014 Document type: Article Affiliation country: Switzerland Country of publication: United States